New Proteomic Analysis Software Offers Unified Solution, a Few Mouse Clicks Can Save Researchers Hundreds of Hours
Athens, GA, June 05, 2008 --(PR.com)-- Bioinquire, LLC announced the release of ProteoIQ, a new software suite for analyzing proteomic data that frees the researcher from the tedious task of sifting through piles of data, and allows him or her to do what they do best – research.
Proteomics, the study of proteins and how they are expressed, can generate gigabytes of data hourly, producing tens to hundreds of hours of hand-indexing and cataloguing per sample. ProteoIQ offers a unified software solution that supports the entire proteomic data analysis pipeline, including data organization, statistical validation, protein quantification, and publication/collaboration.
“Obtaining proteomic data is easy,” said Ron Orlando, co-founder of Bioinquire and researcher at the University of Georgia, who uses mass spectrometry for the analysis of proteins and glycoproteins. “Data handling had become a major bottleneck, and most of my staff was sifting through data, instead of running experiments.”
“The big idea behind ProteoIQ was to convert lists of protein identifications into a format that is easily understood and interpreted by biologists in a few mouse clicks,” said D. Brent Weatherly, Chief Executive Officer and co-founder of Bioinquire.
ProteoIQ is particularly well-suited for comparative proteomic analyses, where spectral counting-based quantification is combined with data mining functions to enable researchers to find differences between multiple proteomic data sets. The software generates statistically validated protein sets, which can then be compared. Proteins that are different across multiple proteomes can be easily identified using the difference function. Taking the intersection of two proteomes allows the researcher to obtain expression levels of those proteins in common.
ProteoIQ incorporates proprietary Protein Validation Technology (ProValT) algorithms licensed from the University of Georgia Research Foundation. This technology, which allows researchers to assign a level of significance to their protein datasets, has already been validated in over 30 published studies.
Initial reviews of ProteoIQ have been very strong. Chemist Robert Graham of University of Ulster said, “The new software (ProteoIQ) is fantastic, really useful and impressive; the use of spectral counting, ability to do intersection, and the linking of proteins to databases is brilliant.” Cancer researcher Lance Wells of the University of Georgia, an early adoptee of ProteoIQ, said, "With its flexibility and functionality, ProteoIQ easily outperforms the competing software."
About Bioinquire:
Bioinquire, LLC is a privately-held bioinformatics software company engaged in the development and commercialization of software solutions for mining the products of mass spectrometric analyses. The company’s strategic advantage is the unique combination of biological, proteomics, and informatics backgrounds of the founders. Bioinquire has received funding from the National Institutes of Health and private sources, including the Georgia Research Alliance. Bioinquire is located at the Georgia BioBusiness Center in Athens, GA. For more information, or to download a trial version of ProteoIQ, visit www.bioinquire.com
Contact: James A. Atwood, III
Chief Operating Officer
Bioinquire, LLC
Phone: 706/583-4000 or 888/291-2246
jatwood@bioinquire.com
###
Proteomics, the study of proteins and how they are expressed, can generate gigabytes of data hourly, producing tens to hundreds of hours of hand-indexing and cataloguing per sample. ProteoIQ offers a unified software solution that supports the entire proteomic data analysis pipeline, including data organization, statistical validation, protein quantification, and publication/collaboration.
“Obtaining proteomic data is easy,” said Ron Orlando, co-founder of Bioinquire and researcher at the University of Georgia, who uses mass spectrometry for the analysis of proteins and glycoproteins. “Data handling had become a major bottleneck, and most of my staff was sifting through data, instead of running experiments.”
“The big idea behind ProteoIQ was to convert lists of protein identifications into a format that is easily understood and interpreted by biologists in a few mouse clicks,” said D. Brent Weatherly, Chief Executive Officer and co-founder of Bioinquire.
ProteoIQ is particularly well-suited for comparative proteomic analyses, where spectral counting-based quantification is combined with data mining functions to enable researchers to find differences between multiple proteomic data sets. The software generates statistically validated protein sets, which can then be compared. Proteins that are different across multiple proteomes can be easily identified using the difference function. Taking the intersection of two proteomes allows the researcher to obtain expression levels of those proteins in common.
ProteoIQ incorporates proprietary Protein Validation Technology (ProValT) algorithms licensed from the University of Georgia Research Foundation. This technology, which allows researchers to assign a level of significance to their protein datasets, has already been validated in over 30 published studies.
Initial reviews of ProteoIQ have been very strong. Chemist Robert Graham of University of Ulster said, “The new software (ProteoIQ) is fantastic, really useful and impressive; the use of spectral counting, ability to do intersection, and the linking of proteins to databases is brilliant.” Cancer researcher Lance Wells of the University of Georgia, an early adoptee of ProteoIQ, said, "With its flexibility and functionality, ProteoIQ easily outperforms the competing software."
About Bioinquire:
Bioinquire, LLC is a privately-held bioinformatics software company engaged in the development and commercialization of software solutions for mining the products of mass spectrometric analyses. The company’s strategic advantage is the unique combination of biological, proteomics, and informatics backgrounds of the founders. Bioinquire has received funding from the National Institutes of Health and private sources, including the Georgia Research Alliance. Bioinquire is located at the Georgia BioBusiness Center in Athens, GA. For more information, or to download a trial version of ProteoIQ, visit www.bioinquire.com
Contact: James A. Atwood, III
Chief Operating Officer
Bioinquire, LLC
Phone: 706/583-4000 or 888/291-2246
jatwood@bioinquire.com
###
Contact
Bioinquire, LLC
Ron Orlando
1-888-291-2246
www.bioinquire.com
Ron Orlando
1-888-291-2246
www.bioinquire.com
Contact
Categories